{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:33:27Z","timestamp":1781292807808,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:00:00Z","timestamp":1362528000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Within the genus <jats:italic>Aspergillus<\/jats:italic>, <jats:italic>A. flavus<\/jats:italic> is the second most important species of clinical significance. It is predominantly associated with infections involving sinuses, eye and skin, mostly in geographic regions with hot and arid climate, including the Middle East. Recent reports on emergence of resistance to triazoles among <jats:italic>Aspergillus<\/jats:italic> spp. is a cause of concern for treatment of patients with invasive aspergillosis. In this study we present data on genetic characterization and antifungal susceptibility profile of clinical and environmental isolates of <jats:italic>A. flavus.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Ninety-nine <jats:italic>Aspergillus<\/jats:italic> section <jats:italic>Flavi<\/jats:italic> isolates, originating from clinical (n=92) and environmental (n=7) sources, initially identified by morphological characteristics, were analyzed by partial sequencing of \u03b2-tubulin and calmodulin gene fragments and their susceptibilities to six antifungal agents was determined by Etest on RPMI1640 and Muller-Hinton agar media. Etest minimum inhibitory concentrations (MICs) of amphotericin B and voriconazole were also compared with zone of inhibition diameters obtained by disc diffusion test on RPMI agar medium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The identity of all clinical and environmental isolates was confirmed as <jats:italic>A. flavus<\/jats:italic> species by combined analysis of \u03b2-tubulin and calmodulin genes. The mean MIC<jats:sub>90<\/jats:sub> (\u03bcg\/ml) values on RPMI medium for amphotericin B, voriconazole, posaconazole, anidulafungin, micafungin and caspofungin were 3, 0.25, 0.25, 0.002, 0.002 and 0.032, respectively. No environmental isolate exhibited MIC value of &gt;2 \u03bcg\/ml for amphotericin B. For clinical isolates, the zone of inhibition diameters for amphotericin B and voriconazole ranged from 7\u201316 mm and 24\u201334 mm, respectively. Linear regression analysis between Etest MIC values and disk diffusion diameters revealed a significant inverse correlation with amphotericin B (<jats:italic>p<\/jats:italic> &lt;0.001) and voriconazole (<jats:italic>p<\/jats:italic>&lt;0.003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The \u03b2-tubulin and calmodulin gene sequences confirmed that all 92 clinical isolates identified phenotypically belonged to <jats:italic>A. flavus<\/jats:italic> taxon<jats:italic>,<\/jats:italic> thus suggesting that the other species within <jats:italic>Aspergillus<\/jats:italic> section <jats:italic>Flavi<\/jats:italic> are of little clinical significance. Triazoles and echinocandins showed very good <jats:italic>in vitro<\/jats:italic> activity against the <jats:italic>A. flavus,<\/jats:italic> however, 10% clinical isolates showed MICs of &gt;2 \u03bcg\/ml for amphotericin B.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-13-126","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T01:54:13Z","timestamp":1362621253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait"],"prefix":"10.1186","volume":"13","author":[{"given":"Faten","family":"Al-Wathiqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziauddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"2318_CR1","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1086\/317487","volume":"31","author":"EJ Dasbach","year":"2000","unstructured":"Dasbach EJ, Davies GM, Teutsch SM: Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis. 2000, 31: 1524-1528. 10.1086\/317487.","journal-title":"Clin Infect Dis"},{"key":"2318_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","volume":"52","author":"S Krishnan","year":"2009","unstructured":"Krishnan S, Manavathu EK, Chandrasekar PH: Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses. 2009, 52: 206-222. 10.1111\/j.1439-0507.2008.01642.x.","journal-title":"Mycoses"},{"key":"2318_CR3","first-page":"588","volume":"49","author":"G Hageskal","year":"2011","unstructured":"Hageskal G, Kristensen R, Fristad RF, Skaar I: Emerging pathogen Aspergillus calidoustus colonizes water distribution systems. Med Mycol. 2011, 49: 588-593.","journal-title":"Med Mycol"},{"key":"2318_CR4","first-page":"755","volume":"49","author":"D Coelho","year":"2011","unstructured":"Coelho D, Silva S, Vale-Silva LS, Gomes H, Pinto EN, Sarmento AN, Pinheiro M: Aspergillus viridinutans: an agent of adult chronic invasive aspergillosis. Med Mycol. 2011, 49: 755-759.","journal-title":"Med Mycol"},{"key":"2318_CR5","first-page":"581","volume":"21","author":"FA Fadl","year":"2000","unstructured":"Fadl FA, Hassan KM, Faizuddin M: Allergic fungal rhinosinusitis: report of 4 cases from Saudi Arabia. Saudi Med J. 2000, 21: 581-584.","journal-title":"Saudi Med J"},{"key":"2318_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.amjoto.2003.12.003","volume":"25","author":"SH Al-Dousary","year":"2004","unstructured":"Al-Dousary SH: Allergic fungal sinusitis: radiological and microbiological features of 59 cases. Am J Otolaryngol. 2004, 25: 213-218. 10.1016\/j.amjoto.2003.12.003.","journal-title":"Am J Otolaryngol"},{"key":"2318_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00405-002-0547-x","volume":"260","author":"SJ Taj-Aldeen","year":"2003","unstructured":"Taj-Aldeen SJ, Hilal AA, Chong-Lopez A: Allergic Aspergillus flavus rhinosinusitis: a case report from Qatar. Eur Arch Otorhinolaryngol. 2003, 260: 331-335. 10.1007\/s00405-002-0547-x.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2318_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0256-4947.51772","volume":"28","author":"SJ Taj-Aldeen","year":"2008","unstructured":"Taj-Aldeen SJ, Hilal AA, Schell WA: Allergic fungal rhinosinusitis: a report of 8 cases. Ann Saudi Med. 2008, 28: 17-21. 10.4103\/0256-4947.51772.","journal-title":"Ann Saudi Med"},{"key":"2318_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.mycmed.2010.09.002","volume":"20","author":"MT Hedayati","year":"2010","unstructured":"Hedayati MT, Bahoosh M, Kasiri A, Ghasemi M, Motahhari SJ, Poormosa R: Prevalence of fungal rhinosinusitis among patients with chronic rhinosinusitis from Iran. J Med Mycol. 2010, 20: 298-303. 10.1016\/j.mycmed.2010.09.002.","journal-title":"J Med Mycol"},{"key":"2318_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1099\/jmm.0.46549-0","volume":"56","author":"ZU Khan","year":"2007","unstructured":"Khan ZU, Ahmad S, Mokaddas E, Said T, Nair MP, Halim MA, Nampoory MR, McGinnis MR: Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1@@3)-beta-D-glucan in clinical specimens. J Med Microbiol. 2007, 56: 129-132. 10.1099\/jmm.0.46549-0.","journal-title":"J Med Microbiol"},{"key":"2318_CR11","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","volume":"153","author":"MT Hedayati","year":"2007","unstructured":"Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW: Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology. 2007, 153: 1677-692. 10.1099\/mic.0.2007\/007641-0.","journal-title":"Microbiology"},{"key":"2318_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1439-0507.1997.tb00217.x","volume":"40","author":"ZU Khan","year":"1997","unstructured":"Khan ZU, Sanyal SC, Mokaddas E, Vislocky I, Anim JT, Salama AL, Shuhaiber H: Endocarditis due to Aspergillus flavus. Mycoses. 1997, 40: 213-217. 10.1111\/j.1439-0507.1997.tb00217.x.","journal-title":"Mycoses"},{"key":"2318_CR13","volume-title":"Reference method for broth dilution antifungal susceptibility testing for filamentous fungi; approved standard. Document M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing for filamentous fungi; approved standard. Document M38-A2. 2008, Wayne, PA: Clinical and Laboratory Standards Institute"},{"key":"2318_CR14","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1128\/AAC.00686-11","volume":"55","author":"A Espinel-Ingroff","year":"2011","unstructured":"Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, Fuller J, Ghannoum M, Johnson E, Pelaez T, Pfaller MA, Turnidge J: Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011, 55: 5150-5154. 10.1128\/AAC.00686-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"2318_CR15","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1128\/AAC.01730-10","volume":"55","author":"A Espinel-Ingroff","year":"2011","unstructured":"Espinel-Ingroff A, Fothergill A, Fuller J, Johnson E, Pelaez T, Turnidge J: Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011, 55: 2855-2859. 10.1128\/AAC.01730-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"2318_CR16","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1128\/JCM.00536-10","volume":"48","author":"A Espinel-Ingroff","year":"2010","unstructured":"Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, Rinaldi MG, Canton E, Turnidge J: Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol. 2010, 48: 3251-7. 10.1128\/JCM.00536-10.","journal-title":"J Clin Microbiol"},{"key":"2318_CR17","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3201\/eid1710.110226","volume":"17","author":"JW van der Linden","year":"2011","unstructured":"van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJ, Verweij PE: Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009. Emerg Infect Dis. 2011, 17: 1846-1854. 10.3201\/eid1710.110226.","journal-title":"Emerg Infect Dis"},{"key":"2318_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jac\/dkr443","volume":"67","author":"A Chowdhary","year":"2012","unstructured":"Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF: Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother. 2012, 67: 362-366. 10.1093\/jac\/dkr443.","journal-title":"J Antimicrob Chemother"},{"key":"2318_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1128\/JCM.41.1.403-409.2003","volume":"41","author":"A Espinel-Ingroff","year":"2003","unstructured":"Espinel-Ingroff A: Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol. 2003, 41: 403-409. 10.1128\/JCM.41.1.403-409.2003.","journal-title":"J Clin Microbiol"},{"key":"2318_CR20","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1128\/JCM.40.6.2101-2107.2002","volume":"40","author":"A Espinel-Ingroff","year":"2002","unstructured":"Espinel-Ingroff A, Rezusta A: E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol. 2002, 40: 2101-2107. 10.1128\/JCM.40.6.2101-2107.2002.","journal-title":"J Clin Microbiol"},{"key":"2318_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2012.01.006","volume":"73","author":"AI Martos","year":"2012","unstructured":"Martos AI, Mart\u00edn-Mazuelos E, Romero A, Serrano C, Gonz\u00e1lez T, Almeida C, Puche B, Cant\u00f3n E, Pem\u00e1n J, Espinel-Ingroff A: Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp. Diagn Microbiol Infect Dis. 2012, 73: 53-56. 10.1016\/j.diagmicrobio.2012.01.006.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2318_CR22","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3109\/13693781003586943","volume":"48","author":"AI Martos","year":"2010","unstructured":"Martos AI, Romero A, Gonz\u00e1lez MT, Gonz\u00e1lez A, Serrano C, Castro C, Pem\u00e1n J, Cant\u00f3n E, Mart\u00edn-Mazuelos E: Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol. 2010, 48: 858-861. 10.3109\/13693781003586943.","journal-title":"Med Mycol"},{"key":"2318_CR23","volume-title":"Identification of common Aspergillus species","author":"MA Klich","year":"2002","unstructured":"Klich MA: Identification of common Aspergillus species. 2002, Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures Publication"},{"key":"2318_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2007.04.009","volume":"59","author":"S Ahmad","year":"2007","unstructured":"Ahmad S, Khan ZU, Theyyathel AM: Diagnostic value of DNA, (1\u20133)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diagn Microbiol Infect Dis. 2007, 59: 165-171. 10.1016\/j.diagmicrobio.2007.04.009.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2318_CR25","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1128\/JCM.00150-12","volume":"50","author":"Z Khan","year":"2012","unstructured":"Khan Z, Ahmad S, Al-Ghimlas F, Al-Mutairi S, Joseph L, Chandy R, Sutton DA, Guarro J: Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate. J Clin Microbiol. 2012, 50: 1800-1804. 10.1128\/JCM.00150-12.","journal-title":"J Clin Microbiol"},{"key":"2318_CR26","unstructured":"European Committee on Antimicrobial Susceptibility Testing: 2013, (http:\/\/www.eucast.org\/antifungal_susceptibility_testing_afst\/): Antifungal agents - Breakpoint tables for interpretation of MICs, Version 5.0"},{"key":"2318_CR27","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1128\/JCM.00393-11","volume":"49","author":"A Espinel-Ingroff","year":"2011","unstructured":"Espinel-Ingroff A, Canton E, Fothergill A, Ghannoum M, Johnson E, Jones RN, Ostrosky-Zeichner L, Schell W, Gibbs DL, Wang A, Turnidge J: Quality control guidelines for amphotericin B, itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with non-supplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte filamentous fungi. J Clin Microbiol. 2011, 49: 2568-2571. 10.1128\/JCM.00393-11.","journal-title":"J Clin Microbiol"},{"key":"2318_CR28","volume-title":"Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd ed","author":"Clinical Laboratory Standards Institute","year":"2008","unstructured":"Clinical Laboratory Standards Institute: Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd ed. 2008, Villanova, PA: CLSI document M23-A3: Clinical and Laboratory Standards Institute"},{"key":"2318_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3114\/sim.2011.69.05","volume":"69","author":"J Varga","year":"2011","unstructured":"Varga J, Frisvad JC, Samson RA: Two new aflatoxin producing species, and an overview of Aspergillus section Flavi. Studies Mycol. 2011, 69: 57-80. 10.3114\/sim.2011.69.05.","journal-title":"Studies Mycol"},{"key":"2318_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ijantimicag.2012.01.013","volume":"39","author":"C Colozza","year":"2012","unstructured":"Colozza C, Posteraro B, Santilli S, De Carolis E, Sanguinetti M, Girmenia C: In vitro activities of amphotericin B and Am Bisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies. Int J Antimicrob Agents. 2012, 39: 440-443. 10.1016\/j.ijantimicag.2012.01.013.","journal-title":"Int J Antimicrob Agents"},{"key":"2318_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jac\/42.4.497","volume":"42","author":"C Lass-Fl\u00f6rl","year":"1998","unstructured":"Lass-Fl\u00f6rl C, Kofler G, Kropshofer G, Hermans J, Kreczy A, Dierich MP, Niederwieser D: In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother. 1998, 42: 497-502. 10.1093\/jac\/42.4.497.","journal-title":"J Antimicrob Chemother"},{"key":"2318_CR32","first-page":"429","volume":"15","author":"P Badiee","year":"2012","unstructured":"Badiee P, Alborzi A, Moeini M, Haddadi P, Farshad S, Japoni A, Ziyaeyan M: Antiungal susceptibility of the Aspergillus species by Etest and CLSI reference methods. Arch Iran Med. 2012, 15: 429-432.","journal-title":"Arch Iran Med"},{"key":"2318_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3109\/13693786.2012.684154","volume":"50","author":"I Hadrich","year":"2012","unstructured":"Hadrich I, Makni F, Neji S, Cheikhrouhou F, Bellaaj H, Elloumi M, Ayadi A, Ranque S: Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012, 50: 829-834. 10.3109\/13693786.2012.684154.","journal-title":"Med Mycol"},{"key":"2318_CR34","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1128\/JCM.00535-08","volume":"46","author":"MA Pfaller","year":"2008","unstructured":"Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ: In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J Clin Microbiol. 2008, 46: 2568-2572. 10.1128\/JCM.00535-08.","journal-title":"J Clin Microbiol"},{"key":"2318_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/0301-4738.67072","volume":"58","author":"V Mittal","year":"2010","unstructured":"Mittal V, Mittal R, Sharma PC: Voriconazole-refractory fungal infection of phacoemulsification tunnel. Indian J Ophthalmol. 2010, 58: 434-437. 10.4103\/0301-4738.67072.","journal-title":"Indian J Ophthalmol"},{"key":"2318_CR36","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1128\/AAC.05477-11","volume":"56","author":"W Liu","year":"2012","unstructured":"Liu W, Sun Y, Chen W, Liu W, Wan Z, Bu D, Li R: T778G mutation in cyp51C gene confers voriconazole-resistance in Aspergillus flavus causing aspergillosis. Antimicrob Agents Chemother. 2012, 56: 2598-2603. 10.1128\/AAC.05477-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"2318_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ijantimicag.2008.06.018","volume":"32","author":"S Krishnan-Natesan","year":"2008","unstructured":"Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK: Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents. 2008, 32: 519-524. 10.1016\/j.ijantimicag.2008.06.018.","journal-title":"Int J Antimicrob Agents"},{"key":"2318_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijantimicag.2006.09.019","volume":"29","author":"R Araujo","year":"2007","unstructured":"Araujo R, Pina-Vaz C, Rodrigues AG: Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Int J Antimicrob Agents. 2007, 29: 108-111. 10.1016\/j.ijantimicag.2006.09.019.","journal-title":"Int J Antimicrob Agents"},{"key":"2318_CR39","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1128\/JCM.01155-09","volume":"47","author":"MA Pfaller","year":"2009","unstructured":"Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ: In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. J Clin Microbiol. 2009, 47: 3323-3325. 10.1128\/JCM.01155-09.","journal-title":"J Clin Microbiol"},{"key":"2318_CR40","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","volume":"54","author":"MR Shivaprakash","year":"2011","unstructured":"Shivaprakash MR, Geertsen E, Chakrabarti A, Mouton JW, Meis JF: In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs. Mycoses. 2011, 54: e583-589. 10.1111\/j.1439-0507.2010.01996.x.","journal-title":"Mycoses"},{"key":"2318_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0732-8893(02)00544-8","volume":"45","author":"MA Pfaller","year":"2003","unstructured":"Pfaller MA, Messer SA, Boyken L, Hollis RJ, Diekema DJ: In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. Diagn Microbiol Infect Dis. 2003, 45: 241-244. 10.1016\/S0732-8893(02)00544-8.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2318_CR42","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1128\/JCM.02450-06","volume":"45","author":"SA Messer","year":"2007","unstructured":"Messer SA, Diekema DJ, Hollis RJ, Boyken LB, Tendolkar S, Kroeger J, Pfaller MA: Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi. J Clin Microbiol. 2007, 45: 1322-1324. 10.1128\/JCM.02450-06.","journal-title":"J Clin Microbiol"},{"key":"2318_CR43","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/JCM.38.9.3359-3361.2000","volume":"38","author":"MA Pfaller","year":"2000","unstructured":"Pfaller MA, Messer SA, Mills K, Bolmstr\u00f6m A: In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol. 2000, 38: 3359-3361.","journal-title":"J Clin Microbiol"},{"key":"2318_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1179\/joc.2008.20.1.87","volume":"20","author":"A Ozkutuk","year":"2008","unstructured":"Ozkutuk A, Ergon C, Metin DY, Yucesoy M, Polat SH: Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole. J Chemother. 2008, 20: 87-92.","journal-title":"J Chemother"},{"key":"2318_CR45","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/JCM.41.3.1126-1129.2003","volume":"41","author":"JB Pfaller","year":"2003","unstructured":"Pfaller JB, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA: In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol. 2003, 41: 1126-1129. 10.1128\/JCM.41.3.1126-1129.2003.","journal-title":"J Clin Microbiol"},{"key":"2318_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2006.09.003","volume":"57","author":"J Guinea","year":"2007","unstructured":"Guinea J, Pel\u00e1ez T, Alcal\u00e1 L, Bouza E: Correlation between the Etest and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2007, 57: 273-276. 10.1016\/j.diagmicrobio.2006.09.003.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2318_CR47","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1128\/JCM.00134-07","volume":"45","author":"A Espinel-Ingroff","year":"2007","unstructured":"Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs DL, Wang A: Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol. 2007, 45: 1811-1820. 10.1128\/JCM.00134-07.","journal-title":"J Clin Microbiol"},{"key":"2318_CR48","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1128\/JCM.01883-07","volume":"46","author":"A Espinel-Ingroff","year":"2008","unstructured":"Espinel-Ingroff A, Canton E: Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J Clin Microbiol. 2008, 46: 1793-1803. 10.1128\/JCM.01883-07.","journal-title":"J Clin Microbiol"},{"key":"2318_CR49","volume-title":"Performance standards for antifungal disk diffusion susceptibility testing of non-dermatophyte filamentous fungi; Informational supplement, 1st ed. CLSI document M51-A","author":"Laboratory Standards Institute","year":"2010","unstructured":"Laboratory Standards Institute: Performance standards for antifungal disk diffusion susceptibility testing of non-dermatophyte filamentous fungi; Informational supplement, 1st ed. CLSI document M51-A. 2010, Wayne, PA: Clinical and Laboratory Standards Institute"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-126\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:37:36Z","timestamp":1630535856000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-126","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]},"assertion":[{"value":"10 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"126"}}